Croma-Pharma (Croma) announced that the decentralized procedure for its botulinum toxin to gain market authorization in Europe has been accomplished. This important step is the basis to complete Croma’s already

This content is restricted to site members. If you are an existing user, please log in. New users may register below.

Existing Users Log In